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Peter Murray-Rust35, Eric Neumann36, Oliver Reubenacker37, Matthias Samwald38,39, Martijn van Iersel40,
Sarala Wimalaratne41, Keith Allen42, Burk Braun11, Michelle Whirl-Carrillo43, Kei-Hoi Cheung44,
Kam Dahlquist45, Andrew Finney46, Marc Gillespie47, Elizabeth Glass29, Li Gong43, Robin Haw7,
Michael Honig48, Olivier Hubaut5, David Kane49, Shiva Krupa50, Martina Kutmon51, Julie Leonard42,
Debbie Marks52, David Merberg53, Victoria Petri54, Alex Pico55, Dean Ravenscroft56, Liya Ren14, Nigam Shah57,
Margot Sunshine34, Rebecca Tang43, Ryan Whaley43, Stan Letovksy58, Kenneth H Buetow59, Andrey Rzhetsky60,
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Biological Pathway Exchange (BioPAX) is a standard language
to represent biological pathways at the molecular and cellular
level and to facilitate the exchange of pathway data. The
rapid growth of the volume of pathway data has spurred the
development of databases and computational tools to aid
interpretation; however, use of these data is hampered by the
current fragmentation of pathway information across many
databases with incompatible formats. BioPAX, which was
created through a community process, solves this problem
by making pathway data substantially easier to collect,
index, interpret and share. BioPAX can represent metabolic
and signaling pathways, molecular and genetic interactions
and gene regulation networks. Using BioPAX, millions of
interactions, organized into thousands of pathways, from many
organisms are available from a growing number of databases.
This large amount of pathway data in a computable form will
support visualization, analysis and biological discovery.
Increasingly powerful technologies, including genome-wide molecular
measurements, have accelerated progress toward a complete map of
molecular interaction networks in cells and between cells of many organisms. The growing scale of these maps requires their representation in
a form suitable for computer processing, storage and dissemination
*A

Challenges posed by the many fragmented pathway databases
The total volume of pathway data mapped by biologists and stored
in databases has entered a rapid growth phase, with the number of
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by means of software systems. The BioPAX project aims to facilitate
knowledge representation, systematic collection, integration and wide
distribution of pathway data from heterogeneous information sources.
This will enable these data to be incorporated into distributed biological
information systems that support visualization and analysis.
BioPAX supports efforts working toward a complete representation of basic cellular processes. Biology has come a long way since
the Boehringer-Mannheim wall chart of metabolic pathways1 and the
Nicholson Metabolic Map2. Since then, several groups have developed
methods and databases for organizing pathway information3–16, but
only recently have groups collaborated as part of the BioPAX project
to develop a generally accepted standard way of representing these
pathway maps. Complete molecular process maps must include all
interactions, reactions, dependencies, influence and information flow
between pools of molecules in cells and between cells. For ease of use
and simplicity of presentation, such network maps are often organized
in terms of subnetworks or pathways. Pathways are models delineated
within the entire cellular biochemical network that help us describe and
understand specific biological processes. Thus, a useful definition of a
pathway is a set of interactions between physical or genetic cell components, often describing a cause-and-effect or time-dependent process,
that explains observable biological phenomena. How do we represent
these pathways in a generally accepted and computable form?

SEPTEMBER 2010

935

© 2010 Nature America, Inc. All rights reserved.

Perspective
online resources for pathways and molecular interactions increasing
70%, from 190 in 2006 to 325 in 2010 (ref. 17). In addition, molecular
profiling methods, such as RNA profiling using microarrays, or protein quantification using mass spectrometry, provide large amounts of
information about the dynamics of cellular pathway components and
increase the power of pathway analysis techniques18,19. However, this
growth poses a formidable challenge for pathway data collection and
curation as well as for database, visualization and analysis software,
as these data are often fragmented.
The principal motivation for building pathway databases and software tools is to facilitate qualitative and quantitative analysis and
modeling of large biological systems using a computational approach.
Over 300 pathway or molecular interaction–related data resources17
and many visualization and analysis software tools3,20–22 have been
developed. Unfortunately, most of these databases and tools were
originally developed to use their own pathway representation language, resulting in a heterogeneous set of resources that are extremely
difficult to combine and use. This has occurred because many different research groups, each with their own system for representing
biomolecules and their interactions in a pathway, work independently
to collect pathway data recorded in the literature (estimated from
text-mining projects23 to be present in at least 10% of the >20
million articles currently indexed by PubMed). As a result, researchers
waste time collecting information from different sources and converting it from one form of representation to another. Fragmented
pathway data results in substantial lost opportunity cost. For instance,
visualization and analysis tools developed for one pathway database
cannot be reused for others, making software development efforts
more expensive. Therefore, it is imperative to develop computational
methods to cope with both the magnitude and fragmented nature of
this expanding, valuable pathway information. Whereas independent
research efforts are needed to find the best ways to represent pathways, community coordination and agreement on standard semantics is necessary to be able to efficiently integrate pathway data from
multiple sources on a large scale.
BioPAX requirements and implementation
A common, inclusive and computable pathway data language is
necessary to share knowledge about pathway maps and to facilitate
integration and use for hypothesis testing in biology24. A shared
language facilitates communication by reducing the number of translations required to exchange data between multiple sources (Fig. 1).
Developing such a representation is challenging owing to the variety
of pathways in biology and the diverse uses of pathway information.
Pathway representations frequently use abstractions for metabolic,
signaling, gene regulation, protein interaction and genetic interaction,
and these serve as a starting point toward a shared language25. Also,
several variants of this common language may be required to answer
relevant research questions in distinct fields of biology, each covering
unique levels of detail addressing different uses, but these should be
rooted in common principles and must remain compatible.
BioPAX addresses these challenges. We developed BioPAX as a
shared language to facilitate communication between diverse software systems and to establish standard knowledge representation of
pathway information. BioPAX supports representation of metabolic
and signaling pathways, molecular and genetic interactions and gene
regulation. Relationships between genes, small molecules, complexes
and their states (e.g., post-translational protein modifications, mRNA
splice variants, cellular location) are described, including the results
of events. Details about the BioPAX language are available in online
documentation at http://www.biopax.org/. The BioPAX language
936
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Figure 1 BioPAX is a shared language for biological pathways. BioPAX
reduces the effort required to efficiently communicate between pathway
users, databases and software tools. Without a shared language, each
system must speak the language of all other systems in the worst case
(black lines). With a shared language, each system only needs to speak
that language (central red box).

provides terms and descriptions, to represent many aspects of biological pathways and their annotation. It is implemented as an ontology,
a formal system of describing knowledge (Box 1) that helps structure
pathway data so that they are more easily processed by computer
software (Fig. 2). It provides a standard syntax used for data exchange
that is based on OWL (Web Ontology Language) (Box 1). Finally, it
provides a validator that uses a set of rules to verify whether a BioPAX
document is complete, consistent and free of common errors. BioPAX
is the only community standard for biological pathway exchange to
and from databases, but it is related to other standards (discussed
below in the “What is not covered?” section).
Example of a pathway in BioPAX
Pathway models are generally described with text and with network
diagrams. Here we use the AKT signaling pathway26,27 as an example
to show how a typical pathway diagram that can only be interpreted
by people (Fig. 3, top left) would be represented using BioPAX (Fig. 3,
right). The AKT pathway is a cell surface receptor–activated signaling
cascade that transduces external signals to intracellular events through
a series of steps including protein-protein interactions and protein
kinase–mediated phosphorylation. The pathway eventually activates
transcription factors, which turn on genes to promote cell survival.
By representing the pathway using the BioPAX language (Fig. 3 and
Supplementary Tables 1 and 2), it can be analyzed by computational
approaches, such as pathway analysis of gene expression data.
Representing a pathway using the BioPAX language sometimes
necessitates being more explicit to avoid capturing inconsistent data.
For instance, the typical notion of an ‘active protein’ is dependent
on context, as the same molecule could be active in one cellular
context, such as a cellular compartment with a set of potentially
interacting molecules, and inactive in another context. Thus, capturing the specific mechanism of activation, such as phosphorylation
modification, is usually required, and the presence of downstream
events that include the modified form signifies that the molecule is
active. Interactions where the mechanism of action is unknown can
also be specified.
What does BioPAX include?
BioPAX covers all major concepts familiar to biologists studying pathways, including metabolic and signaling pathways, gene regulatory
networks and genetic and molecular interactions (Supplementary
Table 3). The BioPAX language is distributed as an ontology definition
(Fig. 4) with associated documentation, a validator for checking
a BioPAX document for errors and other software tools (Table 1).
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An ontology is a formal system for representing knowledge64. Such representation is required for computer software to make use of
information. Example ontologies include organism taxonomies65 and the Gene Ontology40. A formal representation allows consistent
communication of knowledge among individuals or computer systems and helps manage complexity in information processing as knowledge is broken down into clear concepts that can be considered independently. Ontologies also enable integration of knowledge between
independent resources linked on the World Wide Web. Such linked, structured data form the basis of the semantic web, an extension of
the web that promises improved information management and search capability61. Representing and sharing knowledge using ontologies
is simplified by availability of the standard web ontology language (OWL; http://www.w3.org/TR/owl-features/). Tools to edit OWL, such
as Protégé63, have been developed by the semantic web community and adopted in the life sciences. Implementing BioPAX using OWL
enables both the ontology and the individuals and values to be stored in the same XML-based format, which makes data transmission
easier. Using OWL also enables BioPAX users to take advantage of existing software tools for editing, transmitting, querying, reasoning
about and visualizing OWL data.
An ontology is composed of classes, properties (representing relations) and restrictions and is used to define individuals (instances
of classes, also known as objects) and values for their properties. Classes (also known as concepts or types) are often arranged into a
hierarchy (or taxonomy) where child classes are more specific than, and inherit the properties of, parent classes. For example, in
BioPAX, the BiochemicalReaction class is a subclass of the Conversion class. Classes may have properties (also known as fields,
attributes or slots), which express possible relations to other classes (that is, they may have values of specific types). For example,
a SmallMolecule is related to the ChemicalStructure class by the property structure. Restrictions (also known as constraints) define
allowable values and connections within an ontology. For example, molecularWeight must be a positive number. Individuals are
instances of classes where values occupy the properties of those instances. BioPAX defines the classes, properties and restrictions
required to represent biological pathways and leaves creation of the individuals to users (data providers and consumers).
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r epresents this as a pair of genes that participate in a ‘genetic inter
action’ measured using an observed ‘phenotype’. Genetic interactions
use BioPAX classes: Gene, GeneticInteraction.
Metabolic-, signaling- and gene regulatory–pathway abstractions
are process oriented. They imply a temporal order and can be thought
of as extensions of the standard chemical reaction pathway notation
to accommodate biological information. Molecular and genetic inter
actions, however, imply a static network of connections among system
components, instead of the temporally ordered process of reactions
that defines a metabolic or signaling pathway. BioPAX supports combining these different types of data into a single model that is useful
to gain a more complete view of a cellular process.
Pathway information processing
Data

Formalize

Publish

Use

Publication about
a biological
process

Scientist
Traditional

Pathway abstractions frequently used in several pathway databases
and software programs are supported as follows:
• Metabolic pathways are described using the ‘enzyme, substrate,
product’ abstraction28 where substrates and products of a biochemical reaction are often small molecules. An enzyme, often a protein,
catalyzes the reaction, and inhibitors and activators can modulate the
catalysis event. Metabolic pathways use BioPAX classes: PhysicalEntity,
Conversion, Catalysis, Modulation, Pathway.
• Signaling pathways involve molecules and complexes participating
in biochemical reactions, binding, transportation and catalysis events
(Fig. 3)5,9,29–31. These pathways may also include descriptions of mole
cular states (such as cellular location, covalent and noncovalent modifica
tions, as well as fragments of sequence cleaved from a precursor) and
generic molecules (such as the family of homologous Wnt proteins).
Signaling pathways use BioPAX classes: PhysicalEntity, Conversion,
Control, Catalysis, Modulation, MolecularInteraction, Pathway.
• Gene regulatory networks involve transcription and translation
events and their control12,14. Transcription, translation and other
template-directed reactions involving DNA or RNA are captured in a
‘template reaction’ in BioPAX, which maps a template to its encoded
products (e.g., DNA to mRNA). Multiple sequence regions on a
single strand of the template, such as promoters, terminators, open
reading frames, operons and various reaction machinery binding sites, are active in a template reaction. Transcription factors
(generally proteins and complexes), microRNAs and other molecules,
participate in a ‘template reaction regulation’ event. Gene regulatory
networks use BioPAX classes: PhysicalEntity, TemplateReaction,
TemplateReactionRegulation.
• Molecular interactions, notably protein-protein 32–36 and
protein-DNA interactions 37, involve two or more ‘physical entities’. BioPAX follows the standard representation scheme of the
Proteomics Standards Initiative Molecular Interaction (PSI-MI)
format38. Molecular interactions use BioPAX classes: PhysicalEntity,
MolecularInteraction.
• Genetic interactions occur between two genes when the phenotypic consequence of perturbing both genes is different than expected
given the phenotypes of each single gene perturbation39. BioPAX

Computable

© 2010 Nature America, Inc. All rights reserved.

Box 1 What is an ontology?

Prior models
Data
observations

Publication about
a biological
process

Scientists

P

BioPAX
ontology
BioPAX
record

P

Software

Figure 2 BioPAX enables computational data gathering, publication
and use of information about biological processes. Traditional pathway
information processing: observations considering prior models published
as text and figures. Computable pathway information processing:
scientist’s description represented using formal, computable framework
(ontology) published in a format readable by computer software for
analysis by scientists.
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rAKT1 is a ProteinReference
has standard-name “AKT1”
has name “PKB”
has xref Uniprot-P31749
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AKT1.1 is a Protein
has proteinReference rAKT1
has notFeature p@308
has notFeature p@473
reaction1 is a BiochemicalReaction
has left AKT1.2
has right AKT1.1
is left-to-right.

PDK1

PP2A

p@308 is a ModificationFeature
has featureLocation AKT1-308
has modificationType
phosphorylation

P 308
P 473

HSP90

catalysis1 is a Catalysis
has controller PP2A.1
has controlled reaction1
has direction irr-left-to-right
AKT1.2 is a Protein
has proteinReference rAKT1
has feature p@308
has notFeature p@473
assembly1 is a ComplexAssembly
has left HSP90.1
has left AKT1.3
has right complex1
is reversible
complex1 is a Complex
has component AKT1.4
has component HSP90.2
HSP90.2 is a Protein
has proteinReference rHSP90
is boundTo AKT1.4

HSP90

AKT1

P 308
P 473

AKT1.4 is a Protein
has proteinReference rAKT1
has feature p@308
has feature p@473
is boundTo HSP90.2

BioPAX provides many additional constructs, not shown in Figure 4,
that are used to store extra details, such as database cross-references,
chemical structure, experimental forms of molecules, sequence feature
locations and links to controlled vocabulary terms in other ontologies
(Supplementary Fig. 1). BioPAX reuses a number of standard controlled
vocabularies defined by other groups. For example, Gene Ontology40
is used to describe cellular location, PSI-MI vocabularies38 are used to
define evidence codes, experimental forms, interaction types, relationship types and sequence modifications, and Sequence Ontology41 is used
to define types of sequence regions, such as a promoter region on DNA
involved in transcription of a gene. Other useful controlled vocabularies
can be referenced, such as the molecule role ontology42.
BioPAX defines additional semantics that are currently only captured in documentation. For instance, physical entities represent
pools of molecules and not individual molecules, corresponding to
typical semantics used when describing pathways in textbooks or
databases. A molecular pool is a set of molecules in a bounded area
of the cell, thus it has a concentration. Pools can be heterogeneous
and can overlap, as in the case of a protein existing in multiple phosphorylation states.
BioPAX also defines a range of constructs that are represented as
ontology classes. Some of these represent biological entities, such as
proteins, and are organized into classes that conceptualize the pathway knowledge domain. Others are used to represent annotations
and properties of the database representation of biological entities.
For instance, BioPAX provides ‘xref ’ classes to represent different
kinds of references to databases that can be useful for data integration.
These are represented as subclasses of UtilityClass for convenience.
A future version of BioPAX would ideally capture these semantics
and structure these concepts more formally.
Uses of pathway data encoded in BioPAX
Once pathway data are translated into a standard computable language,
such as BioPAX, it is easier for software to access them and thereby
938

Figure 3 The AKT pathway as represented by a traditional method (top left;
from http://www.biocarta.com/), a formalized SBGN diagram (left; from
http://www.sbgn.org/62) and using the BioPAX language (right). An important
advantage of the BioPAX representation is that it can be interpreted by
computer software and used in multiple ways, including automatic diagram
creation, information retrieval and analysis. Online documentation at
http://www.biopax.org/ contains more details about how to represent diverse
types of biological pathways. Actual samples of pathway data in BioPAX
OWL XML format are available in Supplementary Tables 1 and 2.

support browsing, retrieval, visualization and analysis (Fig. 5). This
enables efficient reuse of data in different ways, avoiding the timeconsuming and often frustrating task of translating them between
formats (Fig. 1). Additionally, it enables uses that would be impractical
without a standard format, such as those dependent on combining all
available pathway data.
BioPAX can be used to help aggregate large pathway data sets by
reducing the required collection and translation effort, for instance
using software such as cPath43. Typical biological queries, such as
‘What reactions involve my protein of interest?’ generate more complete answers when querying these larger pathway data sets. Another
frequent use is to find pathways that are active in a particular biological context, such as a cell state determined by a genome-scale
molecular profile measurement. For instance, pathways with multiple differentially expressed genes may be transcriptionally active
in one biological condition and not in another. Functional genomics and pathway data can be imported into software and combined
for visualization and analysis to find interesting network regions.
A typical workflow involves overlaying molecular profiling data, such
as mRNA transcript profiles, on a network of interacting proteins
to identify transcriptionally active network regions, which may
represent active pathways44. A number of recent papers have used
this pathway analysis workflow to highlight genes and pathways
that are active in specific model organisms or diseased tissues, such
as breast cancer, using gene and protein expression, copy number
variants and single-nucleotide polymorphisms19,44–49. BioPAX has
also been used in a number of these studies to collect and integrate
large amounts of pathway information from multiple databases for
analysis. For instance, protein expression data were combined with
pathway information to highlight the importance of apoptosis in a
mouse model of heart disease50. Multiple groups have found that
tumor-associated mutations are significantly related by pathway
Table 1 What is included in BioPAX
Content

Description

Ontology specification

Web Ontology Language (OWL) XML file, developed
using free Protégé ontology editor software63.
Explanation of BioPAX entities, example documentation, best practice recommendations, use cases
and instructions for carrying out frequently used
technical tasks.
Example files for biochemical pathway, protein and
genetic interaction, protein phosphorylation, insulin
maturation, gene regulation and generic molecules
in OWL XML.
Recommendations for graphical representation using
Systems Biology Graphical Notation (SBGN) as a guide.
Java programming library supporting import/export,
conversion and validation. Can be used to add
BioPAX support to software.
Databases making data available in BioPAX format,
software systems for storing, visualizing and
analyzing BioPAX pathways.

Language documentation

Example files

Graphical representation
Paxtools software

List of data sources and
supporting software
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TemplateReaction

Control

Conversion

Protein properties
availability (String*)
name (String*)
-comment (String*)
xref (Xref*)
data Source (Provenance*)
evidence (Evidence*)
feature (Entity-Feature*)
not Feature (Entity-Feature*)
member Physical Entity (Protein*)
cellular Location
(Cellular-Location-Vocabulary*)
entity Reference (Protein-Reference)

MolecularInteraction

Figure 4 High-level view of the BioPAX ontology.
Classes, shown as boxes and arrows, represent
inheritance relationships. The three main
types of classes in BioPAX are Pathway (red),
Interaction (green) and PhysicalEntity and
Gene (blue). For brevity, the properties of the
Protein class only are shown as an example at
the top right. Asterisks indicate that multiple
values for the property are allowed. Refer to
BioPAX documentation at http://www.biopax.org/
for full details of all classes and properties.

GeneticInteraction

What is not covered?
The BioPAX language uses a discrete representation of biological pathways. Dynamic
Biochemical
Complex
Modulation
Catalysis
Transport
Reaction
Assembly
and quantitative aspects of biological processes, including temporal aspects of feedback
loops and calcium waves, are not supported.
TemplateReactionRegulation
TransportWithBiochemicalReaction
Degradation
However, BioPAX addresses this need by coordinating work (as described below) with the
information47,48. And recently, in a study of rare copy number vari- SBML and CellML mathematical modeling language communities55,56
ants in 996 individuals with autism spectrum disorder, a core set of and a growing software tool set supporting biological process
neuronal development–related pathways were found to link dozens simulation57. Detailed information about experimental evidence supof rare mutations to autism that were not significantly linked to the porting elements of a pathway map is useful for evaluating the qualdisorder on their own by traditional single-gene association statis- ity of pathway data. This information is only included in BioPAX for
tics49. These studies highlight the importance of pathway information molecular interactions, because that was already defined by the PSI-MI
in explaining the functional consequence of mutations in human language58 and it was reused The BioPAX work group makes use of
disease. BioPAX pathway data can also be converted into simula- PSI-MI–controlled vocabularies and other concepts and works with
tion models, for instance using differential equations51 or rule-based the PSI-MI work group to build these vocabularies in areas of shared
modeling languages52, to predict how a biological system may func- interest, such as genetic interactions. Although BioPAX does not aim to
tion after a gene is knocked out.
standardize how pathways are visualized, work is coordinated with the
BioPAX is useful for exchanging information among and between
data providers and analysis software. Pathway database groups
Data exchange between database groups
can share the effort of pathway curation by making their pathways
available in BioPAX format and exchanging them with others. For
Database 1
Export
Import
Database 2
example, pathways in BioPAX format from the Reactome8 database
are imported by the US National Cancer Institute/Nature Pathway
Information Database9. Data providers can use existing BioPAXAKT1
enabled software to add useful new features to their systems. For
PDK1
Pathway visualization from database
example, the Cytoscape network visualization software20 can read and
PP2A AKT1
display BioPAX-formatted data as a network. The Reactome group
Visualization
Database 1
Export
used this feature to create a pathway visualization tool for their websoftware
PDK2
site. Because Reactome data were available in BioPAX format, and
AKT1
Cytoscape could already read BioPAX format, this new feature was
HSP90
easy to implement.
Pathway analysis of genomics data
The Paxtools Java programming library for BioPAX has been
developed to help software developers readily support the import,
export and validation of BioPAX-formatted data for various uses in
their software (http://www.biopax.org/paxtools/). Using Paxtools
Pathway
data
and other tools, a range of BioPAX-compatible software has been
developed, including browsers, visualizers, querying engines,
editors and converters (Supplementary Table 4). For instance,
the ChiBE and VisANT pathway-visualization tools read BioPAX
Analysis
software
format 22, and the WikiPathways website 53, a community wiki
Find active
for pathways, is working on using BioPAX to help import pathpathways
Genomics
ways from several sources, including manually edited pathways
data
from biologists. The Pathway Tools software 21 and CellDesigner
pathway editor54 are developing support for BioPAX-based data
exchange. In addition, tools for the storage and querying of
Resource Description Framework (http://www.w3.org/RDF/) data
sets, generated within the Semantic Web community, can be used Figure 5 Example uses of pathway information in BioPAX format. Redcolored boxes or lines indicate the use of BioPAX.
to effectively process BioPAX data.
308
473

P 308
473

P 308
P 473
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Figure 6 The relationship among popular standard formats for pathway information. BioPAX and
PSI-MI are designed for data exchange to and from databases and pathway and network data
integration. SBML and CellML are designed to support mathematical simulations of biological
systems and SBGN represents pathway diagrams.

How does the BioPAX community work?
Whereas BioPAX facilitates communication
of current knowledge, it is challenging for all
knowledge-representation efforts to anticipate new forms of information. As new types of pathway data and new knowledge representation
languages and tools become available, the BioPAX language must
evolve through the efforts of a community of scientists that includes
biologists and computer scientists.
BioPAX is developed through community consensus among data
providers, tool  developers and pathway data users. More than 15
BioPAX workshops have been held since November 2002, attended by a
diverse set of participants. Incremental versions, also called levels, of the
BioPAX language were progressively developed at these workshops to
focus the group’s efforts on attainable intermediate goals. Broader input
came from mailing lists and a community wiki. Community members
participated in developing functionality they were interested in, which
was integrated into specific levels (Supplementary Table 5). Level 1
supports metabolic pathways. Level 2 adds support for molecular interactions and post-translational protein modifications by integrating data
structures from the PSI-MI format. Level 3 adds support for signaling
pathways, molecular state, gene regulation and genetic interactions
(Supplementary Table 3). It is anticipated that newer BioPAX levels
replace older ones, so use of the most recent BioPAX level 3 is currently
recommended. To ease the burden on users and developers, BioPAX
aims to be backwards compatible where practical. Level 2 is backwards
compatible with level 1; however, level 3 involved a major redesign that
necessitated breaking backwards compatibility. This said, many core
classes have remained the same in levels 1, 2 and 3, and software is provided for updating older BioPAX pathways to level 3 (via Paxtools). All
BioPAX material (Table 1) is made freely available under open source
licenses through a central website (http://www.biopax.org/) to encourage broad adoption. The database and tool support (Supplementary
Table 4) of a common language aids the creation, analysis, visualization
and interpretation of integrated pathway maps.
In addition to the creation of a shared language for data and software, the process of achieving community consensus spurs innovation in the field of pathway informatics. Community discussion helps
resolve technical knowledge representation issues faced by many
940
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Systems Biology Graphical Notation (SBGN;
http://sbgn.org/) community, via members of
both communities who attend BioPAX and
SBGN meetings, to ensure that SBGN can be
used to visualize BioPAX pathways. Currently,
most BioPAX concepts can be visualized using
SBGN process description and SBGN activity
flow diagrams and a mapping of BioPAX to
SBGN entity relationship diagrams is under
development. BioPAX development is coordinated with the above standardization efforts
through regular communication between
workgroups to ensure complementarity and
compatibility. For instance, controlled vocabularies developed by PSI-MI and BioPAX can
be used to annotate SBML and CellML models
(Fig. 6). BioPAX aims to be compatible with
these and other efforts, so that pathway data
can be transformed between alternative representations when needed. PSI-MI to BioPAX
and SBML to BioPAX converters are available
(Supplementary Table 4).

Visualization

Perspective

data providers and users and facilitates the convergence to common terminology and representation. Solutions are discovered in
independent research groups and incorporated in new data models
and community best practices, which then enable identification of
new issues. Thus, community workshops support a positive feedback
cycle of knowledge sharing that has led to an accepted BioPAX language and development of better software and databases. We expect
this to continue and to support new scientific uses of pathway information, motivated by end-user access to valuable integrated pathway
information and efficiency gain for database and software development groups. This will especially benefit new pathway databases
and software tools that adopt standard representation and software
components from the start.
Future community goals
The BioPAX shared language is a starting point on the path to developing complete maps of cellular processes. Additional near and longterm goals remain to be realized to enable effective integration and
use of biological pathway information, as described below.
Data collection. Data must be collected and translated to a standard format for them to be integrated. This process is underway, as
the descriptions of millions of interactions in thousands of pathways
across many organisms from multiple databases are now available
in BioPAX format. However, vast amounts of pathway data remain
difficult to access in the literature and in databases that don’t yet
support standard formats. Increasing use of standards requires promoting and supporting data curation teams and automating more
of the data collection process using software. Easy-to-use tools for
tasks like pathway editing must also be developed so that biologists
can share their data in BioPAX format without substantial resource
investment. Ideally, appropriate software would allow authors to enter
data directly in standard formats during the publication process, to
facilitate annotation and normalization by curators before incorporation into databases for use by researchers53.
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Validation and best practice development. To aid data collection,
major data providers and others must develop community best
practice guidelines and rules to help diverse groups use BioPAX consistently when multiple ways of encoding the same information exist.
This will enable data providers to benefit from automatic syntactic
and semantic validation of their data so they can ensure they are
sharing data using standard representation and best practices59,60.
Data collection and automatic validation will facilitate convergence
to generally accepted biological process models.
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Semantic integration. Several models of the same biological process
may usefully co-exist. Ideally, different models could be compared for
analysis and hypothesis formulation. Even so, comparison is difficult
because the same concept can be represented in several ways owing to
use of multiple levels of abstraction (such as the hRas protein versus
the Ras protein family), use of different controlled vocabularies, data
incompleteness or errors. Future research needs to develop semantic
integration solutions that recognize and aid resolution of conflicts.
Visualization. Pathway diagrams are highly useful for communicating pathway information, but it is challenging to automatically construct these diagrams in a biologically intuitive way from pathway data
stored in BioPAX. The SBGN pathway diagram standardization effort
provides a starting point toward achieving this goal (Fig. 3). Intuitive
and automatically drawn biological network visualizations may one
day replace printed biology textbooks as the primary resource for
knowledge about cellular processes.
Language evolution. As uses of pathway information and technology
evolve, so must the BioPAX language. For instance, future BioPAX
levels should capture cell-cell interactions, be better at describing
pathways where sub-processes are not known or need not be represented, more closely integrate third-party controlled vocabularies and
ontologies to ease their use and better encode semantics for easier data
validation and reasoning.
Many groups within the BioPAX community, including most pathway data providers and tool developers, are working to achieve the
above goals. For instance, Pathway Commons (http://www.pathwaycommons.org/) aims to be a convenient single point of access for all
publicly accessible pathway information and the WikiPathways project
(http://www.wikipathways.org/) seeks to enable pathway curation by
individuals53. Also, the semantic web community is developing a set
of technologies that promise to ease the integration of information dispersed on the World Wide Web61. These technologies will aid pathway
data integration because BioPAX is compatible with them through use
of the W3C standard Web Ontology Language, OWL. All of the above
research and development activities support the vision of data providers sharing computable maps of biological processes in a standard
format for convenient use by a community of pathway researchers.
Note: Supplementary information is available on the Nature Biotechnology website.
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